Physician profile
Peter Niemczyk
NPI 1518953041
$6,394.81
in general payments reported to CMS, 2019-2025
14 companies · $3,413 in 2025
The $3,413 reported for 2025 was more than what 88% of Urology providers received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,108 · 2020: $654 · 2021: $521 · 2022: $125 · 2023: $442 · 2024: $133 · 2025: $3,413.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $2,510 · Food and Beverage: $1,462 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $15.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $2,510.17 |
| Food and Beverage | $1,462.09 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $15.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Teleflex LLC | $2,331.16 | 2021-2025 | Urolift, Barrigel |
| Procept Biorobotics Corporation | $1,889.65 | 2024-2025 | Aquabeam System |
| Neotract INC. | $1,011.24 | 2019 | |
| Boston Scientific Corporation | $667.68 | 2019-2020 | |
| Dornier Medtech America, INC | $156.55 | 2025 | Dornier Medtech |
| Myriad Genetic Laboratories, INC. | $90.75 | 2023 | Prolaris |
| Astrazeneca Pharmaceuticals LP | $62.88 | 2023 | Lynparza |
| Pfizer INC. | $38.48 | 2019-2020 | |
| Astellas Pharma US INC | $36.73 | 2021 | |
| Intuitive Surgical, INC. | $27.64 | 2022 | |
| Coloplast Corp | $24.12 | 2019 | |
| Ferring Pharmaceuticals INC. | $22.24 | 2025 | Adstiladrin |
| Janssen Biotech, INC. | $20.69 | 2019 | |
| Becton, Dickinson and Company | $15.00 | 2025 | Bard X-Force Balloon Dilation Catheter |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Peter Niemczyk listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.